Noveome Biotherapeutics Funding: $170M Raised, Series E
Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania. It has raised $170M in total funding. Latest round: Series E. Backed by MAK Capital.
Noveome Biotherapeutics funding overview
Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania. Noveome Biotherapeutics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in April 2025. The round record for Noveome Biotherapeutics runs through 2025; nothing later has been disclosed. Investors on record include MAK Capital.
Noveome Biotherapeutics at a glance
Total raised
$170M
Latest round
Series E
Latest round date
April 2025
Headquarters
Pittsburgh, Pennsylvania
Notable investors
MAK Capital
Frequently asked about Noveome Biotherapeutics funding
How much has Noveome Biotherapeutics raised?
Noveome Biotherapeutics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Noveome Biotherapeutics?
MAK Capital are named among the investors backing Noveome Biotherapeutics.
What was the latest Noveome Biotherapeutics funding round?
The most recent disclosed round is a Series E, announced in April 2025.
Where is Noveome Biotherapeutics based?
Noveome Biotherapeutics is based in Pittsburgh, Pennsylvania.
When did Noveome Biotherapeutics last raise?
The last disclosed Noveome Biotherapeutics round closed in April 2025 at Series E.
Every Noveome Biotherapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Pittsburgh at a similar stage.
